Alimera医疗科学

ALIM NASDAQ
0.4990
-0.0101
-1.98%
休市 16:00 08/16 EDT
开盘
0.5221
昨收
0.5091
最高
0.5409
最低
0.4601
成交量
32.24万
成交均量(3M)
15.85万
52周最高
1.210
52周最低
0.4601
换手率
0.45%
市值
3,542.92万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Alimera医疗科学 ALIM股票价格,Alimera医疗科学股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Alimera Sciences, Inc. (Alimera) is a pharmaceutical company. The Company is engaged in the research, development and commercialization of prescription ophthalmic pharmaceuticals. The Company operates through two segments: U.S. and International. The Company focuses on diseases affecting the back of the eye or retina. The Company's product is ILUVIEN, which is developed to treat diabetic macular edema (DME). DME is a disease of the retina that affects individuals with diabetes and can lead to severe vision loss and blindness. In the United States, ILUVIEN is indicated for the treatment of DME in patients who have been treated with a course of corticosteroids and did not have a rise in intraocular pressure (IOP). In the European Economic Area (EEA) countries, ILUVIEN is indicated for the treatment of vision impairment associated with DME considered insufficiently responsive to available therapies.
展开 >

最近浏览

名称
价格
涨跌幅